Steven Cohen Lexicon Pharmaceuticals, Inc. Transaction History
Point72 Asset Management, L.P.
- $42.2 Billion
- Q4 2024
A detailed history of Steven Cohen (Point72 Asset Management, L.P.) transactions in Lexicon Pharmaceuticals, Inc. stock. As of the latest transaction made, Point72 Asset Management, L.P. holds 8,988,421 shares of LXRX stock, worth $7.01 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
8,988,421
Previous 1,230,050
630.74%
Holding current value
$7.01 Million
Previous $1.93 Million
244.43%
% of portfolio
0.02%
Previous 0.01%
Shares
9 transactions
Others Institutions Holding LXRX
# of Institutions
132Shares Held
245MCall Options Held
52KPut Options Held
178K-
Artal Group S.A. Luxembourg, N4136MShares$106 Million100.0% of portfolio
-
Siren, L.L.C. New York, NY38.9MShares$30.4 Million1.27% of portfolio
-
Black Rock Inc. New York, NY9.89MShares$7.71 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.88MShares$7.71 Million0.0% of portfolio
-
Schonfeld Strategic Advisors LLC New York, NY7.56MShares$5.9 Million0.04% of portfolio
About LEXICON PHARMACEUTICALS, INC.
- Ticker LXRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 188,726,000
- Market Cap $147M
- Description
- Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products. Its orally-delivered small molecule drug candidates under development comprise Sotagliflozin that completed Phase III clinical trials for the for the treatment of heart failure and type 1 diabetes; ...